Neoadjuvant therapy Clinical Trials

5 actively recruiting trials

No change since May 2026

Also known as: Neoadjuvant chemotherapy combined with Serplulimab

Pipeline

Phase 2: 1Phase 3: 3

Top Sponsors

Sun Yat-sen University2
Sichuan Cancer Hospital and Research Institute1
Mansoura University1
Jiuda Zhao1

Indications

Cancer5
Lung Cancer2
Breast Cancer2
Neoadjuvant Therapy2
Concurrent Chemoradiotherapy1

Other5 trials

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase 2

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

N/A

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Phase 3

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 3

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.